Structural and functional characterization of disulfide isoforms of the human IgG2 subclass

被引:219
作者
Dillon, Thomas M. [1 ]
Ricci, Margaret Speed [1 ]
Vezina, Chris [2 ]
Flynn, Gregory C. [3 ]
Liu, Yaoqing Diana [3 ]
Rehder, Douglas S. [1 ]
Plant, Matthew [2 ]
Henkle, Brad [2 ]
Li, Yu [2 ]
Deechongkit, Songpon [1 ]
Varnum, Brian [2 ]
Wypych, Jette [3 ]
Balland, Alain [3 ]
Bondarenko, Pavel V. [1 ]
机构
[1] Amgen Inc, Dept Pharmaceut, Thousand Oaks, CA 91320 USA
[2] Amgen Inc, Dept Inflammat Res, Thousand Oaks, CA 91320 USA
[3] Amgen Inc, Dept Analyt Sci, Thousand Oaks, CA 91320 USA
关键词
D O I
10.1074/jbc.M709988200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the accompanying report ( Wypych, J., Li, M., Guo, A., Zhang, Z., Martinez, T., Allen, M. J., Fodor, S., Kelner, D. N., Flynn, G. C., Liu, Y. D., Bondarenko, P. V., Ricci, M. S., Dillon, T. M., and Balland, A. (2008) J. Biol. Chem. 283, 16194 -16205), we have identified that the human IgG2 subclass exists as an ensemble of distinct isoforms, designated IgG2-A, -B, and -A/ B, which differ by the disulfide connectivity at the hinge region. In this report, we studied the structural and functional properties of the IgG2 disulfide isoforms and compared them to IgG1. Human monoclonal IgG1 and IgG2 antibodies were designed with identical antigen binding regions, specific to interleukin-1 cell surface receptor type 1. In vitro biological activity measurements showed an increased activity of the IgG1 relative to the IgG2 in blocking interleukin-1 beta ligand from binding to the receptor, suggesting that some of the IgG2 isoforms had lower activity. Under reduction-oxidation conditions, the IgG2 disulfide isoforms converted to IgG2-A when 1M guanidine was used, whereas IgG2-B was enriched in the absence of guanidine. The relative potency of the antibodies in cell-based assays was: IgG1 > IgG2-A > IgG2 >> IgG2-B. This difference correlated with an increased hydrodynamic radius of IgG2-A relative to IgG2-B, as shown by biophysical characterization. The enrichment of disulfide isoforms and activity studies were extended to additional IgG2 monoclonal antibodies with various antigen targets. All IgG2 antibodies displayed the same disulfide conversion, but only a subset showed activity differences between IgG2-A and IgG2-B. Additionally, the distribution of isoforms was influenced by the light chain type, with IgG2 lambda composed mostly of IgG2-A. Based on crystal structure analysis, we propose that IgG2 disulfide exchange is caused by the close proximity of several cysteine residues at the hinge and the reactivity of tandem cysteines within the hinge. Furthermore, the IgG2 isoforms were shown to interconvert in whole blood or a "blood-like" environment, thereby suggesting that the in vivo activity of isoforms.
引用
收藏
页码:16206 / 16215
页数:10
相关论文
共 35 条
[1]   The impact of glycosylation on the biological function and structure of human immunoglobulins [J].
Arnold, James N. ;
Wormald, Mark R. ;
Sim, Robert B. ;
Rudd, Pauline M. ;
Dwek, Raymond A. .
ANNUAL REVIEW OF IMMUNOLOGY, 2007, 25 :21-50
[2]   Removal of cysteinylation from an unpaired sulfhydryl in the variable region of a recombinant monoclonal IgG1 antibody improves homogeneity, stability, and biological activity [J].
Banks, Douglas D. ;
Gadgil, Himanshu S. ;
Pipes, Gary D. ;
Bondarenko, Pavel V. ;
Hobbs, Vipa ;
Scavezze, Joanna L. ;
Kim, Jun ;
Jiang, Xu-Rong ;
Mukku, Venkat ;
Dillon, Thomas M. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (02) :775-790
[3]   Human immunoglobulin G2 (IgG2) and IgG4, but not IgG1 or IgG3, protect mice against Cryptococcus neoformans infection [J].
Beenhouwer, David O. ;
Yoo, Esther M. ;
Lai, Chun-Wei ;
Rocha, Miguel A. ;
Morrison, Sherie L. .
INFECTION AND IMMUNITY, 2007, 75 (03) :1424-1435
[4]   HUMAN IGG3 CAN ADOPT THE DISULFIDE BOND PATTERN CHARACTERISTIC FOR IGG1 WITHOUT RESEMBLING IT IN COMPLEMENT-MEDIATED CELL-LYSIS [J].
BREKKE, OH ;
BREMNES, B ;
SANDIN, R ;
AASE, A ;
MICHAELSEN, TE ;
SANDLIE, I .
MOLECULAR IMMUNOLOGY, 1993, 30 (16) :1419-1425
[5]   Therapeutic antibodies for human diseases at the dawn of the twenty-first century [J].
Brekke, OH ;
Sandlie, I .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (01) :52-62
[6]   IMMUNOGLOBULIN-G - FUNCTIONAL SITES [J].
BURTON, DR .
MOLECULAR IMMUNOLOGY, 1985, 22 (03) :161-206
[7]   THE BINDING-AFFINITY OF HUMAN-IGG FOR ITS HIGH-AFFINITY FC RECEPTOR IS DETERMINED BY MULTIPLE AMINO-ACIDS IN THE CH2 DOMAIN AND IS MODULATED BY THE HINGE REGION [J].
CANFIELD, SM ;
MORRISON, SL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (06) :1483-1491
[8]   Effect of copper sulfate on performance of a serum-free CHO cell culture process and the level of free thiol in the recombinant antibody expressed [J].
Chaderjian, WB ;
Chin, ET ;
Harris, RJ ;
Etcheverry, TM .
BIOTECHNOLOGY PROGRESS, 2005, 21 (02) :550-553
[9]   PROBING CONFORMATIONAL-CHANGES IN PROTEINS BY MASS-SPECTROMETRY [J].
CHOWDHURY, SK ;
KATTA, V ;
CHAIT, BT .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1990, 112 (24) :9012-9013
[10]   Optimization of a reversed-phase high-performance liquid chromatography/mass spectrometry method for characterizing recombinant antibody heterogeneity and stability [J].
Dillon, TM ;
Bondarenko, PV ;
Rehder, DS ;
Pipes, GD ;
Kleemann, GR ;
Ricci, MS .
JOURNAL OF CHROMATOGRAPHY A, 2006, 1120 (1-2) :112-120